Speciality: Hematology, Oncology
Language
: Polski
Broadcast type
: Live conference
Duration
: 00:13:30
Date: December 20, 2017
New Drug Program - Ibrutinib in the treatment of patients with chronic lymphocytic leukemia allows to change the perspective on high-risk CLL therapy.
See more